公开(公告)号：US20230233762A1

公开(公告)日：2023-07-27

申请号：US18156497

申请日：2023-01-19

Applicant: INSULET CORPORATION

Inventor： Joon Bok LEE ,  Yibin ZHENG ,  Jason O'CONNOR ,  Kerrie GALLAGHER ,  Lindsay PHILBRICK ,  Alex NGUYEN ,  Joshua WILLIAMS

IPC: A61M5/172 ,  A61B5/145

CPC classification number: A61M5/172 ,  A61B5/14532 ,  A61M2230/201

Abstract: Exemplary embodiments may provide a user interface and logic for assisting a user in calculating a proper medicament bolus dosage. The user interface may be simple and easy to understand. The user interface may clearly specify needed inputs, such as a carbohydrates amount for a meal that is about to be ingested and the current glucose level reading for the user. Entered inputs may be displayed on the user interface. The user interface may depict key calculated values resulting from calculations that involve the inputs, including the total bolus dosage calculation. The user interface also may depict the values that contribute to the total bolus dosage calculation. Some of the input values, such as carbohydrates amount, may be prepopulated by the management device or medicament delivery device. The user interface may permit overriding of prepopulated input values.

公开(公告)号：US20240009392A1

公开(公告)日：2024-01-11

申请号：US18350223

申请日：2023-07-11

Applicant: INSULET CORPORATION

Inventor： Joon Bok LEE ,  Joshua WILLIAMS ,  Jason O'CONNOR ,  Yibin ZHENG ,  Ashutosh ZADE

IPC: A61M5/172 ,  A61M5/142

CPC classification number: A61M5/1723 ,  A61M5/14244 ,  A61M2202/0486

Abstract: Exemplary embodiments may determine anticipated basal insulin delivery action to a user from an insulin delivery device over a future time window. Indications of the anticipated basal insulin delivery action over the future time window may be output to the user. The exemplary embodiments may determine the anticipated basal insulin delivery action over the future time window based on a rate of change (ROC) of glucose level of the user by the insulin delivery device, a most recent (“current”) glucose level for the user and insulin on board (IOB) for the user. The exemplary embodiments may also determine whether the user is likely to experience a undesired high glucose level (e.g., hyperglycemia) and/or an undesired low glucose level (e.g., hypoglycemia) during the future time window. The exemplary embodiments may output recommendations based on the projected glucose levels of the user over the future time window.

公开(公告)号：US20220273873A1

公开(公告)日：2022-09-01

申请号：US17668509

申请日：2022-02-10

Applicant: Insulet Corporation

Inventor： Joshua WILLIAMS ,  Pauline TANDON ,  Mark FIELD ,  Jay JANTZ ,  Steve LOWEN ,  Rangarajan NARAYANASWAMI

IPC: A61M5/172 ,  G16H20/17 ,  G16H50/20 ,  G16H50/30

Abstract: The provided examples of systems, devices and techniques improve systems and methods for keeping users of automatic drug delivery systems engaged and assisting with the optimal use of the drug delivery system. The automatic drug delivery system may include a drug delivery device and a controller. Through the use of an attrition prevention engine in a cloud-based services system that cooperates with an attrition prevention application executing on the controller of the drug delivery device, notifications that include instructions for adjusting operation of the drug delivery device as well as offer assistance to the patient to optimize performance of the drug delivery system for the patient may be provided. Optimizing the performance of the drug delivery system has been shown to prevent attrition of patients from using the drug delivery system.